{"id":"W2786087266","doi":"10.2147/jir.s157358","title":"Clinical utility of ustekinumab in Crohn&amp;rsquo;s disease","year":2018,"lang":"en","type":"review","venue":"Journal of Inflammation Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Canadian Institutes of Health Research; Eisai; Biogen; Amgen; Pfizer; Canadian Association of Gastroenterology","keywords":"Ustekinumab; Medicine; Crohn's disease; Interleukin 23; Tumor necrosis factor alpha; Immunology; Inflammatory bowel disease; Vedolizumab; Adalimumab; Internal medicine; Oncology; Interleukin; Disease; Cytokine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009850489,0.0002848069,0.001070966,0.000714745,0.00006725801,0.00004833515,0.0008785416,0.0005666742,0.0002131471],"category_scores_gemma":[0.006005553,0.000235023,0.0009670927,0.000408616,0.0005267289,0.00001973435,0.0003461536,0.001062349,0.00008163798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000914807,"about_ca_system_score_gemma":0.003452828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003775883,"about_ca_topic_score_gemma":0.00003408687,"domain_scores_codex":[0.9924496,0.002777231,0.002892804,0.0003879484,0.001077499,0.0004148869],"domain_scores_gemma":[0.9948156,0.0002708886,0.001551825,0.0008925757,0.002042751,0.0004263282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003663984,0.0007726169,0.01958952,0.03251805,0.0007218414,0.00130951,0.0000981538,0.00001636775,0.00008749458,0.0001261561,0.02470948,0.9163868],"study_design_scores_gemma":[0.0007805473,0.0001433115,0.04455449,0.005517374,0.0001492428,0.00002609773,0.00001599048,0.00002314607,0.00002037092,0.0001431956,0.9483799,0.0002463724],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1280947,0.8697899,0.00006283604,0.00003255828,0.0004079225,0.0009205313,0.00005611948,0.000003697143,0.0006316713],"genre_scores_gemma":[0.005498541,0.9920059,0.0002004208,0.000007221594,0.001695771,0.00002679124,0.00009919669,0.00004731352,0.0004188071],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9236704,"threshold_uncertainty_score":0.9583962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1819119401562638,"score_gpt":0.4971550086703956,"score_spread":0.3152430685141318,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}